Medicare Enrolled

Dr. Murtaza Mazhar, M.D

Cardiovascular Disease · Galveston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
301 UNIVERSITY BLVD CARDIOVASCULAR DISEASE, Galveston, TX 77555
4097721533
In practice since 2015 (10 years)
NPI: 1275915282 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mazhar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mazhar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mazhar

Dr. Murtaza Mazhar is a cardiovascular disease in Galveston, TX, with 10 years in practice. Based on federal Medicare data, Dr. Mazhar performed 1,467 Medicare services across 1,120 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mazhar received a total of $40,618 from 33 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mazhar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice▲ 1,467 Medicare services$ $40,618 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,467
Medicare services
Bottom 41% in TX for cardiovascular disease
1,120
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~147 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)272$66$123
Office visit, established patient (30-39 min)189$92$173
Hospital follow-up visit, high complexity167$92$127
Ultrasound study of arm or leg veins with compression and maneuvers141$63$157
Initial hospital admission, high complexity132$132$246
Electrocardiogram (EKG), 12-lead119$10$30
Echocardiogram, transthoracic82$52$98
Ultrasound of leg arteries or artery grafts47$114$308
Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel40$49$86
Office visit, established patient (10-19 min)39$24$135
Cardiac catheterization38$185$370
New patient office visit (45-59 min)31$118$226
Nuclear medicine studies of heart muscle at rest and with stress and spect22$59$100
Ultrasound study of one arm or leg veins with compression and maneuvers22$88$231
Chemical destruction of first incompetent vein of arm or leg using imaging guidance20$1,290$2,313
Ultrasound evaluation of blood vessel with review by radiologist, initial vessel19$67$109
New patient office visit (30-44 min)17$72$188
Ultrasound of both sides of head and neck blood flow16$46$116
Removal and dissolving of blood clot from vein using fluoroscopic guidance, initial treatment15$287$481
Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel15$71$120
Review by radiologist of major lower body vein image13$41$78
Remote patient monitoring management, 20 min/month11$37$62
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
23.3% medium
68.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$40,618
Total received (2018-2024)
Avg $5,803/year across 7 years
Top 12% in TX for cardiovascular disease
33
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,659 (68.1%)
Other
Charitable contributions, space rental, and other categories
$7,413 (18.3%)
Scientific / Research
Research funding and grants
$5,154 (12.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$392 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,948
2023
$4,878
2022
$2,752
2021
$6,210
2020
$506
2019
$9,465
2018
$860

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$7,662
Penumbra, Inc.
$6,334
Medtronic, Inc.
$5,596
Abbott Laboratories
$5,516
Inari Medical, Inc.
$4,088
BIOTRONIK INC.
$3,740
Boston Scientific Corporation
$1,589
ABIOMED
$1,577
ShockWave Medical, Inc
$903
BOSTON SCIENTIFIC CORPORATION
$573
Amgen Inc.
$420
Janssen Pharmaceuticals, Inc
$294
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$251
Bard Peripheral Vascular, Inc.
$234
Thrombolex, Inc.
$226
AstraZeneca Pharmaceuticals LP
$203
E.R. Squibb & Sons, L.L.C.
$189
Kestra Medical Technology Services, Inc.
$171
Aziyo Biologics, Inc.
$163
Edwards Lifesciences Corporation
$161
Cardiovascular Systems Inc.
$124
Biosense Webster, Inc.
$102
CHF Solutions, Inc
$101
SANOFI-AVENTIS U.S. LLC
$90
PFIZER INC.
$86
ZOLL Circulation Inc
$48
HEARTFLOW, INC.
$41
Novartis Pharmaceuticals Corporation
$26
LivaNova USA, Inc.
$26
Endologix LLC
$26
Daiichi Sankyo Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$17
Inspire Medical Systems, Inc.
$15
Top 3 companies account for 48.2% of total payments
Associated products mentioned in payments ›
ABRE · ACCOLADE · ACUITY · AFX2 Bifurcated Endograft System · ALTRUA · AURYON LASER SYSTEM 100-120 VAC · Acticor · Aquadex · Assure WCD · Auryon Laser System 100-120 Vac · BRILINTA · Bashir Endovascular Catheter · BioMonitor · CARTO 3 · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · CardioMEMS HF System · Cardiovascular- Research only · Confirm Rx · CoreValve Evolut · Corlanor · DIAMONDBACK PERIPHERAL · Diamondback Coronary · ECM Patch · ELIQUIS · ELUVIA · EMBLEM · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · EkoSonic · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FFRct · FLOWTRIEVER CATHETER · GENERAL BRADY · GENERAL BRADY · GENERAL TACHY · GENERAL - THERAPIES · GENERAL BRADY · General - Therapies · General - Vascular Intervention · HeartMate 3 Left Ventricular Assist Device · INJECTAFER · INSPIRE · Impella · Indigo System · JETI ALL IN ONE NON-STERILE KIT · Kerendia · LIFESPARC · LUTONIX Drug Coated Balloon · LUX-DX · LifeVest · OptiCross · PRALUENT · Penumbra System · Pouch · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · RESOLUTE ONYX · RESONATE · RUBY Coil · Repatha · Resolute · RotarexS 6 F x 135 cm · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Solia · TherOx DS2 Console · VENASEAL · VENOUS WALLSTENT · VYNDAQEL · Varithena Administration Pack · Venovo · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,769 per 100 Medicare services performed
Looking for a cardiovascular disease in Galveston?
Compare cardiovascular diseases in the Galveston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
34
Per 100K population
9.6
County median income
$85,348
Nearest hospital
UNIVERSITY OF TEXAS MEDICAL BRANCH GALVESTON
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mazhar is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 12%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mazhar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mazhar performed 272 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mazhar receive payments from pharmaceutical companies?
Yes. Dr. Mazhar received a total of $40,618 from 33 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mazhar's costs compare to other cardiovascular diseases in Galveston?
Dr. Mazhar's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mazhar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →